Autoimmune diseases, which are classified on the basis of the effector mechanism that causes the symptoms, include all of the following types of hypersensitivity reaction except _____.
a. type I
b. type II
c. type III
d. type IV
a. type I
a. type I: IgE-mediated
b. type II: effector T cells
c. type III: immune complex deposition in tissues
d. type IV: extracellular matrix-associated autoantigens
e. type V: cell-surface components
c. type III: immune complex deposition in tissues
a. subacute bacterial endocarditis
b. Goodpasture syndrome
c. multiple sclerosis
d. systemic lupus erythematosus
e. mixed essential cryoglobulinemia
b. Goodpasture syndrome
a. subacute bacterial endocarditis
b. acute thrombocytopenia purport
c. systemic lupus erythematosus
d. rheumatoid arthritis
e. insulin-resistant diabetes
c. systemic lupus erythematosus
a. pemphigus vulgaris
b. autoimmune thrombocytopenia purpura
c. subacute bacterial endocarditis
d. type 1 diabetes
e. systemic lupus erythematosus
d. type 1 diabetes
a. alpha chain of type IV collagen
b. inflammation
c. extracellular matrix antigen
d. neutropenia and type III hypersensitivity reaction
e. renal tubules and glomeruli
d. neutropenia and type III hypersensitivity reaction
a. pemphigus vulgaris
b. systemic lupus erythematosus
c. rheumatoid arthritis
d. multiple sclerosis
e. Goodpasture s syndrome
b. systemic lupus erythematosus
a. exhibit symptoms of autoimmunity at a young age
b. are unable to activate regulatory T cells
c. exhibit decreased predisposition to autoimmune disease
d. are very effective at inducing anergy of circulating autoreactive B and T cells
e. are more likely to be women of African or Asian origin
a. exhibit symptoms of autoimmunity at a young age
a. HLA-B27: ankylosing spondylitis
b. HLA-DQ2: type 1 diabetes in Africans and Asians
c. HLA-B35: birdshot retinopathy
d. HLA-DR4: rheumatoid arthritis
e. HLA-DQ6: narcolepsy
c. HLA-B35: birdshot retinopathy
a. ankylosing spondylitis
b. systemic lupus erythematosus
c. autoimmune hepatitis
d. myasthenia gravis
e. type 1 diabetes
a. ankylosing spondylitis
a. rheumatoid arthritis
b. multiple sclerosis
c. ankylosing spondylitis
d. Sj gren syndrome
e. Graves disease
c. ankylosing spondylitis
a. weight loss
b. enlarged thyroid gland
c. elevated thyroid-stimulating hormone
d. heat intolerance
e. overproduction of T3 and T4
c. elevated thyroid-stimulating hormone
a. its tyrosine residues are iodinated and cross-linked
b. it is broken down to produce thyroid hormones
c. it is stored in follicles of the thyroid
d. it signals the pituitary gland to stop releasing thyroid-stimulating hormone
e. it is synthesized initially as a glycoprotein by thyroid epithelial cells
d. it signals the pituitary gland to stop releasing thyroid-stimulating hormone
a. Ectopic lymphoid tissue forms and impairs endocrine function.
b. Disruption of adhesion molecules of cellular junctions.
c. Autoimmune response to proteins of anterior chamber of the eye.
d. Chronic inflammation of the gut mucosa.
e. The neuromuscular junction is compromised.
e. The neuromuscular junction is compromised.
a. very little IgM is transported across the placenta
b. only antibodies, and not the B cells making the autoantibodies, cross the placenta
c. the newborn regulatory T cells suppress autoantibody production
d. the newborn thyroid gland develops resistance to the effects of maternal autoantibodies
e. thyroglobulin synthesis does not commence until months after birth
b. only antibodies, and not the B cells making the autoantibodies, cross the placenta
a. pemphigus foliaceus
b. chronic hepatitis C infection
c. Hashimoto disease
d. rheumatoid arthritis
e. multiple sclerosis
a. pemphigus foliaceus
a. cryptic epitope
b. anti-idiotypic antibody
c. molecular mimic
d. receptor antagonist
e. autoantibody
b. anti-idiotypic antibody
a. anti-immunoglobulin autoantibodies
b. Adalumumab
c. leukocyte infiltration in synovial tissue
d. joint inflammation
e. pulmonary hemorrhage and rheumatic fever
e. pulmonary hemorrhage and rheumatic fever
a. 04:01; acidic
b. 04:02; acidic
c. 04:04; basic
d. 04:05; basic
e. 04:08; acidic
b. 04:02; acidic
a. villous atrophy
b. anemia
c. diarrhea
d. tissue ulceration
e. malabsorption
d. tissue ulceration
a. generation of negatively charged peptides that bind well to the positively charged pockets of the DQ2 and DQ8 allotypes
b. conversion of glutamine to glutamate by deamination
c. upregulation during tissue inflammation
d. stimulation of IgG or IgA autoantibodies in celiac disease
e. predisposition to celiac disease if individual possesses particular polymorphic variants
e. predisposition to celiac disease if individual possesses particular polymorphic variants
a. anti-TNF-alpha and anti-CD20
b. anti-C-reactive protein
c. anti-CD14
d. anti-rheumatoid factor
e. anti-CD3
a. anti-TNF-alpha and anti-CD20
a. hypersensitivity reactions
b. innate immune reactions
c. allergic reactions
d. autoimmune diseases
e. anergic reactions
d. autoimmune diseases
a. pulmonary hemorrhage and glomerulonephritis
b. joint inflammation
c. hyperglycemia
d. anti-collagen IgG deposition in renal glomeruli
e. None of the above
a. pulmonary hemorrhage and glomerulonephritis